SPECIFIC METHODS OF INVESTIGATION FOR SARSCOV2 COVID19 VIRUS NOT CONFIRMED COVID19 O.N.A. U99.0 U07.2
Conditions
Interventions
Group 1: Professionals are working in Doctor's Practice in direct contact to patients
Group 2: Professionals are working in Doctor's Practice without direct contact to patients
Group 3: Professionals
Sponsors
Kassenärztliche Vereinigung Thüringen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 18 years ore more, written consent is signed, inclusion is done by statutory insurance physicians in outpatient medical practices
Exclusion criteria
Exclusion criteria: less than 18 years, no written consent, contraindication against blood sampling
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Period prevalence of infection with SARS-CoV-2 and of the resulting immune status (proof of IgG-antibodies against SARS-CoV-2 with a Lateral-Flow-Test plus ELISA) over four points of time | — |
Secondary
| Measure | Time frame |
|---|---|
| Usability of the proof of IgG-antibodies against SARS-CoV-2 as a marker of the postinfection immunity | — |
Countries
Germany
Contacts
Public ContactAnke Möckel
Kassenärztliche Vereinigung Thüringen
Outcome results
None listed